Amicus Curiae Brief — Return Mail, Inc. v. U.S. Postal Serv., 139 S. Ct. 1237 (2019) (No. 17-1594)
Supreme Court brief2019
Ask Donna
What actually matters in this document.
Text
No. 17-1594
In the
Supreme Court of the United States
RETURN MAIL, INC.
Petitioner,
Vv.
UNITED STATES POSTAL SERVICE AND UNITED STATES
Respondents.
On Writ of Certiorari to the
United States Court of Appeals
for the Federal Circuit
BRIEF OF AMICUS CURIAE INTELLECTUAL
PROPERTY OWNERS ASSOCIATION IN SUPPORT
OF NEITHER PARTY
HENRY HADAD LAUREN A. DEGNAN
President Counsel of Record
JAMES TRUSSELL FISH & RICHARDSON P.C.
Chair, Amicus Brief Committee 1000 Maine Avenue S.W.
MARK W. LAUROESCH Suite 1000
Executive Director Washington, DC 20024
INTELLECTUAL PROPERTY (202) 783-5070
OWNERS ASSOCIATION degnan@fr.com
1501 M Street, N.W.
Washington, DC 20005
(202) 507-4500
Counsel for Amicus Curiae
QUESTION PRESENTED
Whether the government is a “person” who
may petition to institute review proceedings
under the America Invents Act (AIA).
TABLE OF CONTENTS
Page
Se TIED dnnsscsicsnncenecesvescnscsncenansesnanens I
TABLE OF AUTHORITIES ......................ccceeeeeeeeeees IV
STATEMENT OF IDENTITY AND INTEREST OF
THE AMICUS CURIAE......0...............:ccecceeeees |
SUMMARY OF ARGUMENT.....................2000---0c00000 2
SIE cisnihinnntatepsisiintintsniimistienintenitaiemmuienaine 4
I. In the AIA, as Elsewhere, the Ordinary
Meaning of “Person” Excludes the
CR i ictteeann A
I. The AIA’s Legislative History Does Not
Contain Indicia that Congress Intended
“Person” To Include the Government ......... 7
A. The AILA’s Estoppel Provisions Do Not
Extend to the Government....................... x
B. Interpreting “Person” to Include the
Government Thwarts Congress's Careful!
Balance of Providing an Efficient Forum
for Challenging Patent Validity While
Avoiding Abusive, Repetitive Validity
1. Prior to the AIA, Congress Relied on
Estoppel to Avoid Repetitive Attacks on
PIE WI cicnesicsensitntaiinnicacersitiimdamidiadinpeensees 1
2. Consistent with Earlier Legislative Acts,
Congress Preserved Estoppel in the AlA’s
Post-Grant Proceedings as an Important
Check on Abusive Litigation......................... 18
Ill. There Is No Per Se Rule Against Estopping
ee I a iccictnsenicnntniicnnisdinninicnints 23
1V. The Government's Other Patent Rights Do
Not Overcome the Presumption That
“Person” Excludes the Government.......... 25
RRS RES A a Se Es SB oA SAR ES 29
EE IRRTRE RSs oa oP bot SE OEE ee MER S la
€
IV
TABLE OF AUTHORITIES
CASES
Ardestani v. INS,
ae Bt Ci icecccesccncccssenssessesonescesss
Aqua Prods., Inc. v. Matal,
872, F.3d 1290 (Fed. Cir. 2017)...............
BIC Leisure Prods., Inc. v. Windsurfing
Int'l, Inc.,
1 F.3d 1214 (Fed. Cir. 1993)....................
Burwell v. Hobby Lobby Stores, Inc.,
SS B,C, Fe Ga i rcencsectescencecscrsevsccnsess
Credit Acceptance Corp. v. Westlake
Servs.,
859 F.3d 1044 (Fed. Cir. 2017)................
Crozier vu. Fried Krupp
Aktiengesellschaft,
Se Wiis Ge Se isescccvccascssccsscsesentavereses
Int'l Primate Prot. League v. Adm’rs of
Tulane Educ. Fund,
is Bee ee iecnccncnensscrcciescssccossesenes
Inyo Cty., Cal. v. Paiute-Shoshone
Indians of Bishop Cmty. of Bishop
Colony,
a eee
Leatherman v. Tarrant Cty. Narcotics
Intelligence & Coordination Unit,
gg RE a ee 28
Merrill Lynch, Pierce, Fenner & Smith,
Inc. v. Curran,
I inincsirsepeiinociiingnanneneceneitit 17, 22
Mohamad v. Palestinian Auth.,
I, nn iesemsnmoonannones 4, 5, 29
Motorola, Inc. v. United States,
729 F.2d 765 (Fed. Cir. 1984).......................++. 9, 26
Office of Pers. Mgmt. v. Richmond,
ee ry Ce i cdccctescecsucsescncsecccess 23, 24, 25
Petrella v. Metro-Goldwyn-Mayer, Inc.,
ER Sn a ne 24
Return Mail, Inc. v. United States
Postal Serv.,
868 F.3d 1350 (Fed. Cir. 2017).................... passim
Synopsys, Inc. v. Mentor Graphics
Corp.,
814 F.3d 1309 (Fed. Cir. 2016)......................00000 11
Tenn. Valley Auth. v. Hill,
cas senhicioneesenns 28
United States v. Am. Trucking Ass’ns,
ee Se icc diicinccisitindsnedmbeninimniiasis 4, 5, 22
Utah Power & Light Co. v. United
NN, SEP ie CINE GI Pi siencicericcncecccintscsccesosnces 23
Vi
Vi. Agency of Nat. Res. v. United States
ex rel. Stevens,
aan Ace OE 7
Will v. Michigan Dep't State Police,
Te NG aera sieciecnininictenctobarntcoorsiecoviies 5
STATUTORY PROVISIONS
SR Re ae a 5, 6
I a a es 22
eR CR i 8, 12
28 U.S.C. § 1498 (1906) ...-...........0..sccsccsccsecsees- passim
ne ELITE ARLE NAT TEN 27
Ee I ii i es 27
i I oni ereccetesscedetiacsancces 27
I oi si irciectdiccmrcieaare 26
OT OI inet tetercecectes 26, 27
I I cicero iceicdaveccntsceoron 28
I I a ississccictstnicnaisciahioeninmines 28
OU IE, RG I isis ecccersenn 6, 12
I I sorts occnintiencecesmeebenesoniasint 12
SET 8, 19, 21
OR OF II snicniceteccsseecncesserenencssiseicrentes 21
Vil
ee te: Oe i iteiacscdesccsonniccioussccicniciemnins 25, 27
ee Sits Oy Se Se crescesecevccseicisenssincoesennocsnnenseneneapitl 6
SD rele Fe See sce cinscnccnnesesenieecscsssesncees 8, 19, 21
a els Oe ee ictrnrtnsineedcnvenncanticiesesnsneinasinins 25, 26
LEGISLATIVE ACTS AND HISTORY
An Act to Provide Additional Protection
for Owners of Patents of the United
States, and for Other Purposes, Pub.
a ny ili iis egcnclinicnbectietgastinseneccnenictcioiciioces 26
Consolidated Appropriations Act, 2000,
OR 8 RE 11
Intellectual Property and
Communications Omnibus Reform
Act of 1999, S. 1948, 106th Cong.
Leahy-Smith America Invents Act, Pub.
ia ets Eee testrinstihasnctinnidantintnethbeahinicnnsinneeatiostiunds passim
Patent Quality Assistance Act of 2004,
H.R. 5299, 108th Cong. (2004) ...................... 14,15
Patent Reexamination Enhancement
Act of 2001, H.R. 2231, 107th Cong.
ERT EE RE ce aren Lec wooo 13, 14
Patent Reform Act of 2009, S. 515,
eS SS Ree 16, 17
Vill
Patent Quality Assistance Act of 2004,
Sata TI iniictiideidiintsdibindsidpndtlentaaienatioenintatiinenéedsda 14,15
145 CONG. REC. (daily ed. Nov. 9, 1999)....... 10, 12,13
147 CONG. REC. (daily ed. June 25,
Sail hietinitenbcsnakabevnbitbabissummabinbiehibeininintemsnnessunseneeies 14
150 Conc. REC. (daily ed. Oct. 11, 2004).................. 14
154 CONG. REC. (daily ed. Sept. 27,
ual cintidehicetddntinusbetiineddutiumnnictudseuseinesinennnsiapeteben 22
157 CONG. REC. (daily ed. Feb. 28, 2011) .....18, 19, 20
157 CONG. REC. (daily ed. Mar. 1, 2011) .................. 20
157 CONG. REC. (daily ed. Mar. 7, 2011) ...............-.- 20
157 CONG. REC.
(daily ed. Mar. 8, 2011)..............000000-- 18, 19, 20, 21
157 CONG. REC. (daily ed. Sept. 6, 2011).................. 18
Fi Bs i, he rt SI cnnccncenesecseusvensocscnsecsnane 16, 17
America Invents Act: Hearing before the
Subcommittee on Intellectual
Property, Competition, and the
Internet of the H. Comm. on the
Judiciary, 112th Cong. (2011)................. 19, 20, 21
IX
Patent Quality Improvement: Post-
Grant Opposition: Hearing before the
Subcommittee on Courts, the
Internet, and Intellectual Property,
H. Comm. on the Judiciary, 108th
ee 15
Patent Reform Act of 2007: Hearing on
H.R. 1908 Before the Subcomm. on
Courts, the Internet, and Intellectual
ge ee 11
Revisor’s Notes, 28 U.S.C. § 1498 (1973) ................. 26
OTHER AUTHORITIES
is I i caer nt daeannmneenanianaenanls 28
Joe Matal, A Guide to the Legislative
History of the America Invents Act:
Part I of Il, 21 Fep. Cir. B.J. 435,
SENET aE a ER Sa a Cc 11
Jeffrey Kushan, The Fruits of the
Convoluted Road to Patent Reform:
The New Invalidity Proceedings of
the Patent & Trademark Office, 30
YALE L. & POL. REV. 385 (2012)......................0225 13
STATEMENT OF IDENTITY AND INTEREST
OF THE AMICUS CURIAE
Amicus curiae Intellectual Property Owners
Association (IPO) is an _ international trade
association representing companies and individuals
in all industries and fields of technology that own or
are interested in intellectual property rights.! [PO's
membership includes roughly 200 companies and
more than 12,000 individuals who are involved in the
association either through their companies or as an
inventor, author, executive, law firm, or attorney
member. Founded in 1972, IPO represents the
interests of its members before Congress and the
USPTO and has filed amicus curiae briefs in this
Court and other courts on significant issues of
intellectual property law. The members of [PO's
Board of Directors, which approved the filing of this
brief, are listed in the Appendix.”
' No counsel for a party authored this brief in whole or in part,
and no such counsel or party made a monetary contribution
intended to fund the preparation or submission of this brief. No
person other than the amicus curiae or its counsel made a
monetary contribution to its preparation or submission. Both
parties have consented to the filing of this brief.
2 IPO procedures require approval of positions in briefs by a
two-thirds majority of directors present and voting.
2
SUMMARY OF ARGUMENT
The Federal Circuit concluded that “the better
reading of ‘person” in the Leahy-Smith America
Invents Act, Pub. L. No. 112-29 (2011) (“AIA”) §
18(a)(1)(B), “does not exclude the government.”
Return Mail, Inc. v. United States Postal Serv., 868
F.3d 1350, 1366 (Fed. Cir. 2017). Yet there is no basis,
in statute or otherwise, to conclude the United States
and its operatives, including Federal agencies (i.e.,
the “government”), is a “person” that can seek to
invalidate a patent by petitioning to institute various
post-grant proceedings enacted in the AIA.
Congress chose the term “person” to identify
those who may seek patent review under the AlA’s
post-grant procedures. Although not a universal
construction, the term “person” has long been
presumed to exclude the sovereign. To overcome this
presumption, one must find clear legislative intent to
the contrary. Here, neither the statutory context nor
the legislative history of the AIA overcomes this
presumption. The plain meaning of “person” is
consistent with the expressed intent of the AlA’s
drafters and the statutory scheme. In contrast,
adopting a more expansive definition of “person”
would thwart legislative intent because it would give
the government two bites at the invalidity apple, in
different fora, wasting time and resources in
contravention of the protections that Congress
carefully balanced and implemented in the AIA. See
Return Mail, 868 F.3d at 1375 (Newman, J.,
dissenting).
3
Congress has long sought to avoid such
repetitive challenges, recognizing it as an abusive
litigation tactic. The AIA’s post-grant proceedings
were designed to expedite and streamline challenges
to patent validity, enabling speedy invalidation of
improperly-granted patents while also avoiding
serial, wasteful attacks. On this latter point, the
application of estoppel, among other checks, is an
important component of the policy considerations
carefully balanced in post-grant review. In crafting
the ALA’s post-grant proceedings, as for earlier patent
reform efforts, Congress incorporated estoppel
provisions that would bar a post-grant petitioner from
bringing duplicative invalidity challenges in a later
forum. To this end, the AIA’s estoppel provisions
retain protections similar to those first enacted in
inter partes reexamination, despite subsequent bills’
proposals to narrow the scope of post-grant estoppel,
indicating that Congress intended to preserve broad
estoppel in the AIA.
Despite the importance of estoppel in the AIA,
however, the Federal Circuit found that the
“government would enjoy the unique advantage of not
being estopped . . . from relitigating grounds raised
during a CBM review proceeding.” Return Mail, 868
F.3d at 1364. Under the Federal Circuit's
interpretation of “person,” the government would not
be estopped from mounting serial patent validity
challenges in post-grant review and again in the
Court of Federal Claims, the only forum in which a
patentee can bring a patent infringement suit against
the government. 28 U.S.C. § 1498(a). This outcome,
dubbed an “oddity” by the Return Mail court, 868 F.3d
A
at 1364, arises because the ALA’s estoppel provisions
extend to subsequent proceedings in only specified
fora, which do not include the Court of Federal
Claims. Such a wasteful and inefficient result is
contrary to Congress’s intent in enacting the AIA,
which requires accused infringers to bring an
invalidity challenge in only one forum. Because the
Federal Circuit’s interpretation runs counter to both
the plain language of the AIA and its underlying
statutory scheme, it is incorrect.
ARGUMENT
1. In the AIA, as Elsewhere, the Ordinary
Meaning of “Person” Excludes the
Government
In determining the meaning of “person” in the
AIA, Congress’ choice of words is of paramount
importance. “There is, of course, no more persuasive
evidence of the purpose of a statute than the words by
which the legislature undertook to give expression to
its wishes.” United States v. Am. Trucking Ass’ns, 310
U.S. 534, 543 (1940) (Am. Trucking”). “Often these
words are sufficient in and of themselves to determine
the purpose of the legislation.” Jd. “Congress remains
free . . . to give the word a broader or different
meaning. But before we will assume it has done so,
there must be some indication Congress intended
such a result.” Mohamad v. Palestinian Auth., 566
U.S. 449, 455 (2012) (emphasis in original).
Accordingly, there is a “strong presumption
that the plain language of the statute expresses
5
congressional intent.” Ardestani v. INS, 502 U.S. 129,
135 (1991) (internal quotation marks omitted); see
also id. at 138 (declining to extend entitlement to fees
and costs under Equal Access to Justice Act to
administrative deportation proceedings in
contravention of statute’s plain language). This
strong presumption “is rebutted only in rare and
exceptional circumstances,” id. at 135 (internal
quotations marks omitted)—namely, “when a
contrary legislative intent is clearly expressed.” /d.;
see also Will v. Michigan Dep't State Police, 491 U.S.
58, 65-66 (1989) (‘Our conclusion that a State is not
a ‘person’ within the meaning of [42 U.S.C.] § 1983 is
reinforced by Congress’ purpose in enacting the
statute.”); Am. Trucking, 310 U.S. at 546-47 (“We are
especially hesitant to conclude that Congress
intended to grant the [Interstate Commerce
Commission] other than the customary power . . . in
view of the absence in the legislative history of the Act
of any discussion of the desirability of giving the
Commission broad and unusual powers .. .”).
Because Congress used the term “person” in
the AIA without providing a special definition, this
Court must presume that Congress intended the term
“person” in the Act to have its plain meaning. See,
e.g., Mohamad, 566 U.S. at 455. The Dictionary Act,
1 U.S.C. § 1 et seq., sets forth the customary meaning
of the term “person,” as used in federal statutes. See,
e.g., Inyo Cty., Cal. v. Paiute-Shoshone Indians of
Bishop Cmty. of Bishop Colony, 538 U.S. 701, 713
(2003) (Stevens, J., concurring). The Dictionary Act
provides that, “unless the context indicates
otherwise,” the term “persor” means “corporations,
6
companies, associations, firms, partnerships,
societies, and joint stock companies, as well as
individuals.” 1 U.S.C. § 1 (2012). Therefore, unless
the context “indicates otherwise,” id., the ordinary
meaning of “person”—-which does not include the
government—must control. Burwell v. Hobby Lobby
Stores, Inc., 134 S. Ct. 2751, 2768 (2014) (“[U]nless
there is something about the [statuvory] context that
‘indicates otherwise,’ the Dictionary Act provides a
quick, clear, and affirmative answer to the question”
of the scope of the term “person”) (quoting 1 U.S.C. §
1). Moreover, because Congress provided that a
“person” could petition for inter partes review, post-
grant review, and covered business method (CBM)
proceedings, the meaning of this term should be
consistent across all AIA patent review proceedings.*
No statutory context, legislative history, or other
evidence indicates that “person” has a meaning other
than its customary definition. See generally Section
B, infra. To the contrary, Congress intended to
preserve estoppel in the AIA’s post-grant proceedings
as a check on wasteful litigation.
® See 35 U.S.C. § 311 (2012) ([A] person who is not the owner of
a patent may file with the Office a petition to institute an inter
partes review of the patent.”); id. § 321 (2012) ([A] person who
is not the owner of a patent may file with the Office a petition to
institute a post-grant review of the patent.”); AIA § 18(a)(1)(B)
CA person may not file a petition for a transitional proceeding
with respect to a covered business method patent unless the
person or the person's real party in interest or privy has been
sued for infringement of the patent or has been charged with
infringement under that patent.”).
Il. The AIA’s Legislative History Does Not
Contain Indicia that Congress Intended
“Person” To Include the Government
This Court’s “conventional reading of ‘person’
may ... be disregarded if the purpose, the subject
matter, the context, the legislative history, or the
executive interpretation of the statute indicate an
intent .. . to bring state or nation within the scope of
the law.” Intl Primate Prot. League v. Adm'rs of
Tulane Educ. Fund, 500 U.S. 72, 83 (1991) (internal
alterations omitted); see also Vi. Agency of Nat. Res.
v. United States ex rel. Stevens, 529 U.S. 765, 781
(2000) (noting the presumption “may be disregarded
only upon some affirmative showing of statutory
intent to the contrary”). Here, there is no statutory
context dictating a meaning of “person” other than its
customary meaning, and construing “person” in this
manner implements Congressional intent. The AlA’s
legislative history demonstrates Congress’s long-
standing interest in preventing serial identical
attacks on patent validity. Congress’s solution to this
problem—in the AIA as well as in prior bills and
statutes—includes strong estoppel provisions. There
is simply no indication that Congress intended the
government to avoid the restrictions that the AIA
imposes on all others. Affirming the Federal Circuit’s
interpretation and permitting the government to
circumvent these protections would frustrate the
AIA’s statutory scheme. Therefore, the term “person”
in the Act should be given its usual meaning.
A. The AIA’s Estoppel Provisions Do Not
Extend to the Government
The AIA’s estoppel provisions dictate that
estoppel arising from post-grant challenges will
attach later in proceedings before the Patent Office,
35 U.S.C. §§ 315(e)(1), 325(e)(1), or “other
proceedings.” Id. §§ 315(e)(2), 325(e)(2) (2012). These
“other proceedings” are clearly specified:
The petitioner . . . of a claim in a patent
under this chapter that results in a final
written decision . . . may not assert
either in a civil action arising in whole or
in part under section 1338 of title 28 or
in a proceeding before the International
Trade Commission .. . that the claim is
invalid... .
Id. § 315(e)(2) (inter partes review); see also id. §
325(e)(2) (post-grant review). Congress therefore
explicitly identified only three fora in which estoppel
against a “person” would lie: the Patent Office, a
“district court| |” under 28 U.S.C. § 1338 (2011), or the
International Trade Commission. Not included in
this list is the Court of Federal Claims. Its absence is
significant because section 1498 provides that the
Court of Federal Claims is the only forum in which a
patentee can seek recourse against the government
for the use or manufacture of a claimed invention. 28
9
U.S.C. § 1498(a) (1996).4 Because the AIA’s estoppel
provisions do not identify the Court of Federal
Claims, the government is not subject to estoppel in
that forum. Return Mail, 868 F.3d at 1364. The
operation of the AIA’s estoppel is consistent with the
usual meaning of “person.” The fora enumerated in
the AIA do not, and need not, include the Court of
Federal Claims, because a “person” does not typically
include the government.
B. Interpreting “Person” to Include the
Government Thwarts Congress’s Careful
Balance of Providing an Efficient Forum
for Challenging Patent Validity While
Avoiding Abusive, Repetitive Validity
Attacks
The Federal Circuit's interpretation of “person”
creates negative consequences for patentees that are
* “Whenever an invention described in and covered by a patent
of the United States is used or manufactured by or for the United
States without license of the owner thereof or lawful right to use
or manufacture the same, the owner's remedy shall be by action
against the United States in the United States Court of Federal
Claims for the recovery of his reasonable and entire
compensation for such use and manufacture.” 28 U.S.C. §
1498(a) (1996). The basis for a patentee’s recovery under Section
1498(a) “is the doctrine of eminent domain.” Motorola, Inc. v.
United States, 729 F.2d 765, 768 (Fed. Cir. 1984) (citing Crozier
v. Fried Krupp Aktiengesellschaft, 224 U.S. 290 (1912)). As the
Federal Circuit recognized, section 1498 “creates ita own
independent cause of action, which is only parallel and not
identical to an infringement action under the Patent Act.”
Return Mail, 868 F.3d at 1361 (internal quotation marks
omitted).
10
plainly at odds with the policies underlying
enactment of the AIA. Congress long sought to
promote patent law reform by creating comparatively
efficient and cost-effective proceedings to invalidate
patents that should not have been granted.® Although
this particular goal, absent more, might not bar
government agencies or operatives from chalienging
patent validity at the Patent Office, the AIA’s drafters
also recognized the importance of precluding
repetitive, wasteful attacks on patents. They built
various protections into the post-grant proceedings —
including estoppel—to avoid such challenges.
The Return Mail court found that that the
government is a “person” in part because, in its view,
no policy reason justified precluding the government
from seeking post-grant review under the AIA.
Return Mail, 868 F.3d at 1366 (“There does not
appear to be any reason . . . to curtail the ability of the
government to initiate a CBM proceeding when, like
a party sued in federal district court or the ITC, it has
interests at stake with respect to the patent it has
been accused of infringing.”). But the court
overlooked a key policy reason why the government
should be excluded from the scope of “person.”
Permitting the government to institute post-grant
review would flout the AIA’s carefully-chosen estoppel
5 In enacting the inter partes reexamination proceeding, the
House Committee noted that “[njJumerous witnesses have
suggested that the volume of lawsuits in district courts will be
reduced if third parties can be encouraged to use reexamination
by giving them an opportunity to argue their case for patent
invalidity in the USPTO.” 145 CONG. Rec. H11804 (daily ed.
Nov. 9, 1999) (Joint Explanatory Statement of the Committee of
Conference).
11
protections, and is inconsistent with Congressional
intent.
1. Prior to the AIA, Congress
Relied on Estoppel to Avoid
Repetitive Attacks on Patent
Validity
A review of the legislative record leading up to
the AIA reveals Congress’s long-standing interest in
preventing serial patent challenges in different fora.
Broad post-grant review, without appropriate checks,
could “subject patent owners to ‘serial post-grant
challenges’ and would deny patent owners the ‘right
to expect quiet title at some point without facing an
endless series of challenges.” See, e.g., Joe Matal, A
Guide to the Legislative History of the America Invents
Act: Part Il of II, 21 Fep. Cir. B.J. 435, 603 (2011)
(quoting Patent Reform Act of 2007: Hearing on H.R.
1908 Before the Subcomm. on Courts, the Internet,
and Intellectual Prop., 110th Cong. 55 (2007)); see also
Synopsys, Inc. v. Mentor Graphics Corp., 814 F.3d
1309, 1327 (Fed. Cir. 2016) (Newman, J., dissenting)
(reviewing legislative history of AIA), overruled on
other grounds by Aqua Prods., Inc. v. Matal, 872 F.3d
1290 (Fed. Cir. 2017).
To avoid this outcome, estoppel—-specifically,
estoppel of a “person”—has been an important
component of patent invalidity proceedings for more
than a decade prior to the AIA, as seen in the 1999
enactment of the inter partes reexamination
12
procedure.® Inter partes reexamination was created
nearly 20 years ago as an avenue for “[a]ny person” to
challenge patent validity. 35 U.S.C. § 311(a) (1999).
To counterbalance a third party’s right to bring this
challenge, the third party would be subject to
estoppel:
A third-party requester . . . is estopped
from asserting at a later time, in any
civil action arising in whole or in part
under section 1338 of title 28 [U.S.C]
the invalidity of any claim finally
determined to be valid and patentable on
any ground which the _ third-party
requester raised or could have raised
during the inter partes reexamination
proceedings.
35 U.S.C. § 315(c) (1999). Notably, Congress intended
the accompanying estoppel to attach broadly because
it covered challenges that the petitioner “could have
raised” as well as those actually raised in the
proceeding. /d. Broad estoppel was a critical
mechanism to effect the balance of concerns raised
during debate over inter partes reexamination. In
introducing this proceeding, members of the House of
Representatives explained that “[t]o prevent
harassment, anyone who requests inter partes
® The inter partes reexamination provisions are set forth in the
Intellectual Property and Communications Omnibus Reform Act
of 1999, S. 1948, 106th Cong. (1999), incorporated by cross-
reference in the conference report to the Consolidated
Appropriations Act, 2000, Pub. L. 106-113 (1999).
13
reexamination must identify the real party in
interest’ and third-party requesters . . . are estopped
from raising in a subsequent court action or inter
partes reexamination any issue of patent validity that
they raised or could have raised during such inter
partes reexamination.” 145 CONG. REC. H11805
(daily ed. Nov. 9, 1999) (Joint Explanatory Statement
of the Committee of Conference). Congress therefore
included estoppel in inter partes reexamination to
prevent patent owners from harassment via serial
identical attacks on patent validity.
Although legislative views on the structure of
patent validity proceedings continued to evolve in the
years leading up to the enactment of the AIA, the
proposed bills consistently reflect the long-standing
importance of maintaining estoppel protections.
When subsequent bills were introduced to reshape
the inter partes reexamination proceeding (among
other parts of the Patent Act) or otherwise change the
scope of post-grant review,® they included estoppel
provisions in some form. Notably, multiple bills
proposed (but not ultimately enacted) leading up to
the AIA contained estoppel provisions that were
narrowed in some respect compared to the protections
in inter partes reexamination. Although these
proposals sought to decrease the scope of estoppel,
broad estoppel was ultimately retained in the
7 35 U.S.C. § 311(b)(1) (1999) (request for inter partes
reexamination must include identity of real party in interest).
® See, e.g., Jeffrey Kushan, The Fruits of the Convoluied Road to
Patent Reform: The New Invalidity Proceedings of the Patent &
Trademark Office, 30 YALE L. & POL. REV. 385, 396-403 (201 2)
(reviewing legislative history of invalidity proceedings reform).
14
proposed post-grant proceedings as a means to
prevent harassing litigation, which was a continuing
concern of lawmakers.
As an_ early example, the Patent
Reexamination Enhancement Act of 2001 (“2001 Act”)
was introduced with a goal of amending the inter
partes reexamination proceeding so that, inter alia,
estoppel would attach after the Patent Office reached
a final determination of patent validity. Patent
Reexamination Enhancement Act of 2001, H.R. 2231,
107th Cong. § 2(c) (2001). Although this proposed
amendment would narrow estoppel in the proceeding,
a requester would, “at the conclusion of
[reexamination] be barred (estopped) from
challenging the patent in any other judicial or [Patent
Office] proceeding. Any issue actually raised or that
could have been raised based on the evidence . . .
before the Patent Office will still be barred...” 147
CONG. REC. E1191 (daily ed. June 25, 2001)
(statement of Rep. Lofgren). Rep. Lofgren, sponsor of
the 2001 Act, noted that the bill was designed to
“ensure that the reexamination procedure retains
important safeguards to prevent third parties from
using the procedure to harass patent owners who hold
valid patents. . . . [A]s noted, the estoppel imposed on
unsuccessful challengers should prevent frivolous
challenges. Those who challenge the patent in the
[Patent Office] will not be able to challenge the patent
later in a court on validity issues.” Id.
A few years later, the Patent Quality
Assistance Act of 2004 (“2004 Act”) was introduced to
expand the scope of post-grant invalidation
15
proceedings by, among other amendments, “relaxing .
estoppel provisions” of the inter partes
reexamination procedure by eliminating estoppel for
arguments the challenger “could have raised” in
reexamination. See 150 CONG. REC. E1936 (daily ed.
Oct. 11, 2004) (statement of Rep. Berman); see also
Patent Quality Assistance Act of 2004, H.R. 5299,
108th Cong. § 7 (2004).9 Despite intending to weaken
the scope of estoppel in _ post-grant review
proceedings, contemporaneous policymakers
nevertheless recognized the importance of
maintaining estoppel in some form. Patent Quality
Improvement: Post-Grant Opposition: Hearing before
the Subcommittee on Courts, the Internet, and
Intellectual Property, H. Comm. on the Judiciary,
108th Cong. 32 (2004) (statement of Michael Kirk,
Executive Director, American Intellectual Property
Law Association) (“A very important aspect of any
post-grant-opposition proceeding is the effect the
decision will have on the parties. If the estoppel
provision is too harsh, no one will use the procedure .
® The 2004 Act also created a new patent opposition proceeding
which permitted broad challenges within nine months of a
patent’s issuance. See 2004 Act §§ 2, 323-24. The new opposition
proceeding incorporated a fairly narrow estoppel provision that
was designed to bar an opposer “from raising, in any subsequent
proceeding involving that opposer . . . any issue of fact or law
actually decided and necessary to the determination of that
issue,” id. § 336(a)(1), with a limited exception for additional
factual evidence necessary and material to the final
determination “that could not reasonably been discovered or
presented ... by that opposer.” Id. § 336(a)(2). The 2004 Act
also would have barred an opposer from bringing an inter partes
reexamination proceeding “on the same claim and on the same
issue” as in the opposition. Id. § 340(a).
16
. If it is too lenient, patentees may be subject to
needless repetitive challenges by the same party.”).'°
Thus, as before, estoppel was recognized as an
important mechanism to curb harassing litigation
tactics, although finding the right balance of
protections remained a challenge.
Similarly, the drafters of the Patent Reform
Act of 2009 (“2009 Act”) sought to re-shape inter
partes reexamination by making the procedure more
robust and efficient while retaining estoppel, albeit
comparatively narrowed. See Patent Reform Act of
2009, S. 515, 111th Cong. (2009).'' Similar to the
© See also id. at 13 (statement of Jeffrey Kushan on behalf of
Genentech, Inc.) (‘The challenge for Congress . . . is to devise a
system that not only provides a rigorous inquiry into the validity
of the patent but is also structured to prevent harassment of the
owners of valid patents. A system that allows frivolous
challenges to be made or which can be used to tie up a patent in
a long and endless administrative proceeding would fail to meet
the needs of those users of the patents community and the needs
of the public.”).
'! As observed by Senator Leahy, under the 2009 Act, a “third
party requester is still estopped from reasserting patent
invalidity in court on any ground actually raised in an inter
partes reexamination, but the ‘or could have raised’ bar is struck.
With respect to serial requests for inter partes reexamination by
the same third party requester or its privies, a final decision . .
will continue to have claim-preclusive effect against subsequent
requests.” S. Rep. NO. 111-18, at 17 (2009). The 2009 Act also
created a new post-grant opposition procedure for use within the
first twelve months after a patent issued. Similar to the 2004
Act’s post-grant review proceeding, this opposition contained
estoppel provisions that precluded a petitioner “from improperly
mounting multiple challenges of a patent or initiating a
challenge after an unfavorable final decision in a civil action
based on grounds the petitioner raised or could have raised.” /d.
17
amendments proposed in the 2004 Act, the 2009 Act
drafters removed validity challenges that “could have
raised” from the scope of the estoppel. The underlying
policy considerations guiding the 2009 Act’s structure
remain familiar. In recommending passage of the
2009 Act, Senator Leahy cautioned that, although its
amendments were intended to remove disincentives
to the current reexamination procedure, “the changes
... are not to be used as tools for harassment .. .
through repeated litigation and administrative
attacks on the validity of a patent. Doing so would
frustrate the purpose of the section as providing quick
and cost effective alternatives to litigation.” S. REP.
No. 111-18, at 18 (2009).
Although these exemplary patent reform bills
were not enacted, they reflect long-standing
legislative interests in preventing repetitive identical
attacks on patent validity. This observation is
significant for a statutory interpretation analysis,
such as in the case at bar, because “the initial focus
must be on the state of the law at the time the
legislation was enacted.” Merrill Lynch, Pierce,
Fenner & Smith, Inc. v. Curran, 456 U.S. 353, 378
(1982) (“More precisely, we must examine Congress’
perception of the law that it was shaping or
reshaping.”). Lawmakers first recognized the
importance of strong estoppel protections in enacting
inter partes reexamination. These subsequent
proposed acts demonstrate estoppel’s continuing
importance as a tool regularly used by Congress to
achieve its policy goals in crafting patent review
proceedings. In its efforts to improve the inter partes
reexamination procedure and to create new post-
18
grant review mechanisms, Congress preserved
estoppel as an important safeguard against abusive
litigation tactics against patent holders. It is little
surprise, therefore, that Congress also recognized the
importance of estoppel when enacting the AIA, and
incorporated it into all AIA post-grant proceedings.
2. Consistent with Earlier
Legislative Acts, Congress
Preserved Estoppel in the
AIA’s Post-Grant Proceedings
as an Important Check on
Abusive Litigation
In general, the policies and considerations
implemented in the AIA’s post-grant proceedings echo
those of earlier bills. See supra Section (I1(B)(1).
Critically, estoppel remained essential to achieving
these legislative goals. Return Mail, 868 F.3d at 1374
(Newman, J., dissenting) (“The estoppel provision is
the backbone of the AIA, for it is through estoppel that
the AIA achieves its purpose of expeditious and
economical resolution of patent disputes without
resort to the courts.”).
Congress intended the AIA’s post-grant
proceedings to reduce abusive litigation tactics,
including serial, repetitive attacks on patent validity.
In describing the “overarching purpose and effect” of
the AIA, Senator Kyl noted that the act would
“ultimately reduce litigation costs” and “cure some
very clear litigation abuses that have arisen under
the current rules, abuses that have done serious harm
to American businesses.” 157 CONG. Rec. $5319
19
(daily ed. Sept. 6, 2011) (statement of Sen. Kyl); see
also 157 CONG. Rec. $1380 (daily ed. Mar. 8, 2011)
(statement of Sen. Grassley) (recognizing need to
“curb litigation abuses”). On this point, the post-
grant review proceedings created in the Act were
intended to “enable early challenges to patents, but
also protect the rights of inventors and patent owners
against endless litigation,” and in front of different
tribunals. 157 CONG. Rec. 8952 (daily ed. Feb. 28,
2011) (statement of Sen. Grassley); see also 157 CONG.
REc. $1364 (daily ed. Mar. 8, 2011) (statement of Sen.
Schumer) (“Too many district courts have been
content to allow litigation to grind on while a
reexamination is being conducted, forcing the parties
to fight in two fora at the same time. This is
unacceptable, and would be contrary to the
fundamental purpose of . . . provid[ing] a cost efficient
alternative to litigation.”).
To achieve this balance, as in previous bills,
estoppel provisions featured as a crucial part of the
AILA’s patent review proceedings. '?
'2 Congress recognized estoppel’s value for the various types of
post-grant proceedings, including covered business method
(CBM) reviews. 35 U.S.C. §§ 315(e) (inter partes review), 325(e)
(post-grant review); Credit Acceptance Corp. v. Westlake Servs.,
859 F.3d 1044, 1049 (Fed. Cir. 2017) (noting that post-grant
review estoppel “also governs CBM review proceedings under
AIA § 18"). As one witness noted, because “[wje don’t want to
have legitimate inventions given to infringers to have second,
third, and fourth bites at the apple. . . | think it’s a good idea . .
. to look at building an estoppel [into CBM proceedings], just like
re-exam procedure.” America Invents Act: Hearing before the
Subcommittee on Intellectual Property, Competition, and the
20
[The ALA was designed to] include a
strengthened estoppel standard to
prevent petitioners from raising in a
subsequent challenge the same patent
issues that were raised or reasonably
could have been raised in a prior
challenge. The bill would significantly
reduce the ability to use post-grant
procedures for abusive serial challenges
to patents. These new procedures would
also provide faster, less costly
alternatives to civil litigation to
challenge patents.
157 CONG. REC. S952 (Feb. 28, 2011) (statement of
Sen. Grassley).'* These estoppel protections were
widely recognized for their value in _ limiting
harassing litigation.'* According to the Patent Office
Internet of the H. Comm. on the Judiciary, 112th Cong. 119
(2011) (2011 AIA Hearing”) (statement of Steven Miller, VP.
and Genera! Counsel, Procter & Gamble Co.).
'§ Other policymakers expressed similar appreciation for
estoppel protections. See 157 CONG. REC. S1041-—42 (Mar. 1,
2011) (statement of Sen. Kyl) (“The present bill does . . . impose
estoppel will effectively bar a third party or related parties from
invoking ex parte reexamination against a patent if that third
party has already employed post-grant or inter partes review
against that patent. Also, the bill allows the Patent Office to
reject any request for a proceeding ... if the same or
substantially the same prior art or arguments previously were
presented to the Office with respect to that patent.”).
'* 157 CONG. REC. $1367 (daily ed. Mar. 8, 2011) (statement of
Sen. Kohl) (recognizing that “[p]atent protection will be stronger
21
Director, David Kappos, “I believe there are
significant advantages for patentees who successfully
go through the post grant system— in this case, inter
partes review——because of those estoppel provisions.
Those estoppel provisions mean that your patent is
largely unchallengeable again by the same party.”
2011 AIA Hearing 52-53.
As further protection, estoppel in the AIA’s
post-grant proceedings was designed to bar those in
privity with the challenger from bringing the same
claims subsequently at the Patent Office or in other
proceedings. 35 U.S.C. §§ 315(e)(1—2), 325(e)(1—2).
|A] party that uses inter partes or post-
grant review is estopped from raising in
a subsequent PTO proceeding any issue
that he raised or reasonably could have
raised in the post-grant or inter partes
review. This effectively bars such a
party or his real parties in interest or
privies from later using inter partes
review.
with the inclusion of ‘could have raised’ estoppel, strong
administrative estoppel, and . . . authority for the [Patent Office]
to reject petitions by third parties and order joinder of related
parties.”); 157 CONG. REC. 81326 (daily ed. Mar. 7, 2011)
(statement of Sen. Sessions) (‘The bill also includes many
protections that were long sought by inventors and patent
owners. It preserves estoppel against relitigating in court those
issues that an inter partes challenger reasonably could have
raised in his administrative challenge.”); see also 2011 AIA
Hearing 93 (statement of John Vaughn, Executive V.P. of
Association of American Universities) (noting such provisions
“reduce the prospect of using the inter partes procedure to mount
harassing serial challenges”).
22
157 CONG. Rec. 81376 (daily ed. Mar. 8, 2011)
(statement of Sen. Kyl) (citing 35 U.S.C. §§ 315(e)(1),
325(e)(1)); accord 35 U.S.C. § 317 (1999) (prohibiting
inter partes reexamination of any claim “on the basis
of issues which that party or its privies raised or could
have raised” in civil litigation or a previous inter
partes reexamination).
The continued inclusion of estoppel provisions
in patent review proceedings, enacted or otherwise,
indicates that estoppel was “part of the contemporary
legal context in which Congress legislated” when
crafting the AIA’s post-grant proceedings. Merrill
Lynch, 456 U.S. at 381. The Merrill Lynch rationale
is instructive. In that case, the Court addressed the
question of whether a private cause of action is
implicit in a federal statutory scheme (the Commodity
Exchange Act (CEA), codified at 7 U.S.C. § 1 (1976) et
seq.) “when the statute by its terms is silent on that
issue.” Jd. at 378. In concluding that a private cause
of action was implied, the Merrill Lynch Court
observed that “the fact that a comprehensive
reexamination and significant amendment of’ the
CEA “left intact the statutory provisions under which
the federal courts had implied a cause of action is
itself evidence that Congress affirmatively intended
to preserve that remedy.” /d. at 381—82. A review of
the CEA’s legislative history “persuasively indicates
that preservation of the remedy was indeed what
Congress actually intended.” /d. at 382.
In the present case, the Federal Circuit
recognized that “absence of Congressional guidance”
23
created a silence as to whether “person” was intended
to apply to the government. Return Mail, 868 F.3d at
1366; see also id. at 1374 (Newman, J., dissenting).
However, preserving estoppel provisions in the AIA’s
post-grant statutes, consistent with the long-standing
use of estoppel in similar proceedings, demonstrate
that Congress intended to not limit the scope of these
protections. This Court should not adopt an
interpretation of “person” that would be at variance
with this legislative policy. See Am. Trucking, 310
U.S. at 543; see also id. at 546-47 (expressing
“hesitan[cy]” about giving federal commission more
than usual power in absence of legislative intent).
Ill. There Is No Per Se Rule Against
Estopping the Government
The Federal Circuit acknowledges that the
government will not be subject to estoppel after an
unsuccessful CBM proceeding. Return Mail, 868 F.3d
at 1364. Although the Government has not been
subject to estoppel in other contexts, see Office of Pers.
Mgmt. v. Richmond, 496 U.S. 414, 421—22 (1990)
(‘Richmond’), the unavailability in one context does
not show that Congress intended for the government
to be free from the estoppel flowing from AIA post-
grant proceedings. Richmond stands for the
unremarkable proposition that the government is not
equitably estopped from denying statutory benefits to
a claimant seeking public funds even if a government
employee misapplies a statute. See id. at 434. The
overarching premise supporting the Richmond
decision is that “the United States is neither bound
nor estopped by acts of its officers or agents in
24
entering into an arrangement or agreement to do or
cause to be done what the law does not sanction or
permit.” /d. (quoting Utah Power & Light Co. v.
United States, 243 U.S. 389, 408-09 (1917)).
The Richmond Court recognized that there was
no per se rule precluding government estoppel.
Richmond, 496 U.S. at 423 (“We leave for another day
whether an estoppel claim could ever succeed against
the Government.”). There is no basis in Richmond to
conclude that the AIA’s estoppel should not operate
against the government. Indeed, the Richmond
opinion expressly leaves that door open. See 496 U.S.
at 426 (“[W]e decline today to accept the . . . argument
for an across-the-board no-estoppel rule.”); see also id.
at 426 (“In our cases . . . reserving the possibility that
estoppel might lie on some facts, we have held only
that the particular facts presented were
insufficient.”). Neither the Return Mail court nor the
United States Postal Service has identified legislative
history or sound policy to explain why Congress would
have intended for the government to be able to make
repeated identical patent validity attacks, and
Richmond does not lead to a different conclusion.
The question of whether the government can be
estopped due to the improper actions of its employees
is not an issue in the present case at all. Here, no
governmental entity misapplied a statute in such a
way as to bind the government to an outcome that
would otherwise run afoul of what the statute
dictates. Furthermore, the nature of the estoppel
considered in Richmond is materially different than
the estoppel built directly into the AIA provisions.
25
The equitable estoppel at issue in Richmond “rests on
misleading.” Petrella v. Metro-Goldwyn-Mayer, Inc.,
572 U.S. 663, 685 (2014). Unlike the federal employee
in Richmond who provided misinformation to the
benefits claimant, there are no wrongful activities at
play here—only the scope and meaning of a statutory
term, “person,” and whether certain patent
challenges are permissible. Moreover, Richmond
narrowly relates to the disbursement of public fur's
to claimants, and, in denying that estoppel attached,
the Richmond Court observed that it took “a most
strict approach to estoppel claims involving public
funds.” Jd. at 426. The ramifications of the only
question before this Court is whether the government
should be exempted from the estoppel that Congress
expressly included in the AIA to bind any “person”
attempting to challenge patent validity.
The Richmond Court was also concerned about
“operation of estoppel against the Government in the
context of payment of money from the Treasury” on
the grounds that it “could in fact render the
Appropriations Clause a nullity.” Richmond, 496
U.S. at 428. But concerns over statutory nullification
actually favor Petitioner Return Mail’s position in
this case. If this Court affirms the Federal Circuit's
statutory interpretation, which abrogates the
statutory estoppel provisions for a particular class of
petitioner, Congress's careful balance’ of
considerations in enacting the AIA will be frustrated.
IV. The Government's Other Patent Rights
Do Not Overcome the Presumption That
“Person” Excludes the Government
26
The Federal Circuit justified its interpretation
by reasoning, inter alia, that “[t]he AIA does not
appear to use the term ‘person’ to exclude the
government in other provisions,” such as _ those
bestowing intervening rights on certain “persons.”
Return Mail, 868 F.3d at 1365 (citing 35 U.S.C. §§
318(c), 328(c) (2012))."®
The legislative history of section 1498 reveals
that Congress intended for the government to have
the defense of intervening rights. Specifically, in
enacting section 1498, Congress intended that the
government have the ability to plead any defense to
patent infringement that would be available to a
private party. See Motorola, 729 F.2d at 769. The
original version of section 1498 expressly provided
that “the United States may avail itself of any and
all defenses, general or special, which might be
pleaded by a defendant in an action for
infringement.” Id. (emphases added).'6 This
language was “omitted as unnecessary” in later
versions of section 1498, but, “[iJn absence of a
'S These provisions refer to the intervening rights “of any person
who made, purchased, or used within the United States, or
imported into the United States, anything patented” by an
amended or new claim following a post-grant proceeding. 35
U.S.C. §§ 318(c), 328(c) (2012); see also id. § 252 (1999)
(governing effect of reissued patents).
‘6 The Motorola court quoted ch. 423, 36 Stat. 851 (cited herein
as An Act to Provide Additional Protection for Owners of Patents
of the United States, and for Other Purposes, Pub. L. No. 305
(1910), noting that this statute was originally codified in Title 35
but later removed and re-codified in Title 28. 729 F.2d at 769 &
n.5.
27
statutory restriction, any defense available to a
private party is equally available to the United
States.” Id. (quoting Revisor’s Notes to 28 U.S.C. §
1498,at 467 (1973)).
Intervening rights is a defense to patent
infringement. See BIC Leisure Prods., Inc. v.
Windsurfing Int'l, Inc., 1 F.3d 1214, 1220 (Fed. Cir.
1993) (“The accused infringer may raise the defense
of intervening rights only when none of the infringed
claims of the reissue patent were present in the
original patent.” (citing 35 U.S.C. § 252 (1988))).
Therefore, in section 1498 actions, the government
may avail itself of the intervening right defense. The
legislative history of section 1498 thus demonstrates
affirmative Congressional intent to overcome the
presumption that a “person” in the particular context
of 35 U.S.C. §§ 252, 318, and 328 does not include the
government.
Section 207 of the Patent Act also reflects
affirmative legislative intent to overcome this
presumption with respect to certain rights of a
“person” in 35 U.S.C. § 102 (2015) (a “person” can be
entitled to a patent if certain conditions are met) and
§ 118 (2012) (a “person” may, under specified
circumstances, “make an application for patent”).
Section 207 empowers the government to protect,
develop, and commercialize patent rights. 35 U.S.C.
§ 207 (2012). In addition to allowing “Federal
agenclies]” to “apply for, obtain, and maintain”
patents, section 207 authorizes the agencies to grant
various kinds of licenses, to transfer title of
inventions, and to “undertake all other suitable and
28
necessary steps to protect and administer rights to
federally owned inventions.” 35 U.S.C. § 207(a;(1-4).
Because the government has the affirmative right to
apply for a patent, interpreting sections 102 and 118
to exclude the government would conflict with section
207. Under these circumstances, the presumption
that “person” in sections 102 and 118 is overcome.
Importantly, section 207 does not contain or
imply provisions by which a Federal agency can seek
to invalidate patents and itself does not use the term
“person” when granting the right, for example, to
apply for, obtain, and maintain” patents. 35 U.S.C. §
207(a)(1). Instead, it uses the term “Federal
agencfies].” Jd. § 207(a). As a result, section 207 does
not demonstrate that “person” in the AIA includes the
government.
Section 303 of the Patent Act likewise does not
overcome the presumption that “person” does not
include the government. Under section 303, the
Patent Office Director “[o]n his own initiative . .. may
determine whether a substantial new question orf
patentability is raised” that would require patent
reexamination. See 35 U.S.C. §§ 303-04 (2012).
Congress explicitly allowed the Patent Office Director
to bring a challenge to patent validity under specified
circumstances. When a statute or rule enumerates
specific actions, it should not ordinarily be extended
to cover possibilities not explicitly addressed therein.
E.g., Leatherman v. Tarrant Cty. Narcotics
Intelligence & Coordination Unit, 507 U.S. 163, 167—
68 (1993) (declining to require heightened pleading
for claims other than exceptions listed in FED. R. Ctv.
29
P. 9(b), on the grounds that “le|xpressio unius est
exclusio alterius”). The explicit authorization in
Section 303 indicates that Federal agencies do not
otherwise have the right to initiate post-grant
proceedings under the AIA. See Tenn. Valley Auth. v.
Hill, 437 U.S. 153, 188, 195 (1978) (although
Endangered Species Act (ESA) created “a number of
limited ‘hardship exceptions,” “there are no
exemptions in the [ESA] for federal agencies,
meaning that under the maxim expressio unius est
exclusio alterius, we must presume that these were
the only ‘hardship cases’ Congress intended to
exempt.”) (affirming injunction of expensive dam
project threatening endangered species).
Considering these statutes together, in light of
traditional principles of statutory construction, “the
statutory context strengthens—not undermines—the
conclusion that Congress intended to create a cause of
action” to invalidate a patent using the AIA’s
procedures by a “person” in the customary sense,
rather than under an expansive interpretation of that
term that would include the government. Mohamad,
566 U.S. at 455.
CONCLUSION
The term “person” in the AIA should be
givenits customary meaning of not including the
government because Congress never explicitly
suggested such a meaning and such interpretation
would frustrate the AIA’s overall structure and
purpose. Allowing the government to take two
identical bites at the invalidity apple—in post-grant
30
proceedings and in the Court of Federal Claims-—
would upset the careful balance Congress struck
when it enacted the AIA. Accordingly, the term
“person” in the AIA should be construed to exclude the
government.
Respectfully submitted,
HENRY HADAD LAUREN A. DEGNAN
President Counsel of Record
JAMES TRUSSELL FISH & RICHARDSON P.C.
Chair, Amicus Brief Committee 1000 Maine Avenue S. W.
MARK W. LAUROESCH Suite 1000
Executive Director Washington, DC 20024
INTELLECTUAL PROPERTY (202) 783-5070
OWNERS ASSOCIATION degnan@fr.com
1501 M Street, N.W.
Washington, DC 20005
(202) 507-4500
Counsel for Amicus Curiae
December 17, 2018
APPENDIX
la
APPENDIX' — MEMBERS OF THE BOARD
OF DIRECTORS INTELLECTUAL PROPERTY
OWNERS ASSOCIATION
Brett Alten Karen Cochran
Hewlett Packard Shell International! B.V.
Enterprise
John D. Conway
Ron Antush Sanofi
Nokia Inc.
Buckmaster de Wolf
Estelle Bakun General Electric Co.
Exxon Mobil Corp.
Robert DeBerardine
Scott Barker Johnson & Johnson
Micron Technology, Inc.
Anthony DiBartolomeo
Edward Blocker SAP AG
Koninklijke Philips NV.
Daniel Enebo
Amelia Buharin Cargill, Ine.
Intellectual Ventures,
LLC Louis Foreman
Enventys
John J. Cheek
Tenneco Inc. Scott M. Frank
AT&T
Cara Coburn
Roche Ince. Darryl P. Frickey
Dow Chemical Co.
1. IPO procedures require approval of positions in briefs by
a two-thirds majority of directors present and voting.
Appendiz
Paik Saber James J. Trussell
Medtronic, Inc BP America, Inc
Matthew Sarboraria Mark Wadrzyk
Oracle USA Inc. Qualcomm Inc
Manny Schecter BJ Watrous
IBM Corp. Apple Inc
Jessica Sinnott Stuart L. Watt
DuPont Amgen, Inc
Thomas Smith Bryan Zielinski
GlaxoSmithKline Pfizer Inc
Todd N. Spalding
Alexion Pharmaceuticals
Daniel Staudt
Siemens Corp
Brian Suffredini
United Technologies
Corp.
Gillian Thackray
Thermo Fisher Scientific
Ine.
Joerg Thomaier
Bayer Intellectual
Property GmbH
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.